Charles E de Bock

28PUBLICATIONS
106CO-AUTHORS
Haematological tumoursFlight dynamicsMusic technology and recordingNanomedicineLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 07, 2026
The case for targeting enhancer regions in high-risk TCF3::HLF-positive B-cell acute lymphoblastic leukemia.

|Jul 23, 2026
Preclinical evaluation of the ROR1-targeting antibody-drug conjugates zilovertamab vedotin and VLS-211 against B-cell ALL patient-derived xenografts.

|Jul 16, 2026
OutFOXing a FENDRR bender in T-ALL.

|Nov 24, 2025
A new KAT on the block rewrites the epigenetic script in menin inhibitor-resistant leukemia.

Yizhou Huang, Charles E de Bock

|Aug 11, 2025
Cell surface surprise: NPM1 is an immune therapy target for acute myeloid leukemia.

Hansen J Kosasih, Charles E de Bock

|Jul 17, 2025
Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewal.

Danielle R Bond, Sean M Burnard, Kumar Uddipto

Pageof 5

Frequent Collaborators

8 joint publications

Jan Cools

7 joint publications

Hansen Kosasih

4 joint publications

Matthew D Dun

3 joint publications

Nicole M Verrills